Published in Women's Health Weekly, January 5th, 2012
"A soluble variant of ST2 (sST2) acts as a decoy receptor to regulate the activity of IL-33. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.